Key Details
Symbol (NSE): SAKSOFT
Corporate Action: Scheme of Amalgamation (Wholly-owned subsidiary merger)
Record Date: Not Specified
Nature of Scheme: Amalgamation of wholly-owned subsidiary into holding company
Entities Involved:
- Transferor Company: Augmento Labs Private Limited (CIN: U72900TN2019PTC183534)
- Transferee Company: Saksoft Limited (CIN: L72200TN1999PLC054429)
Demerged Company: Not Applicable (Amalgamation)
Resulting Company: Saksoft Limited (after amalgamation)
Share Entitlement Ratio: No share issuance. Shares of Transferor Company held by Transferee Company will stand cancelled without any new shares being issued or payment made in cash.
Implied Capital Structure Impact: Not Specified (No dilution as wholly-owned subsidiary merger)
Post-Allotment Listing Plan: Augmento Labs Private Limited will be dissolved without winding up. No separate listing as it merges into existing listed entity Saksoft Limited.
Regulatory and Approval Status:
- NCLT Chennai Bench approved the Scheme vide Order dated 16.09.2026 in CP(CAA)/93(CHE)/2025
- Rectified order issued on 01.10.2026 in IA(CA)/303(CHE)/2026 correcting typographical errors
- Shareholder meetings dispensed with vide Order dated 27.11.2025 in CA(CAA)/73(CHE)/2025
- Regional Director filed report dated 05.06.2026 with observations
- Income Tax Department filed report dated 08.01.2026 with no objections subject to conditions
- Official Liquidator filed report dated 30.03.2026 with observations
- SEBI/Stock Exchange observations: Not required as exemption under Rule 37(6) of SEBI (LODR) Regulations applies for merger of wholly-owned subsidiary
Effective Date: [Effective Date: 01 April 2026] as specified in Clause 1.1.3 of the Scheme
Financial Rationale:
- Consolidation of entities as Transferor Company is wholly-owned subsidiary
- Simplification of Group holding structure by elimination of multiple entities
- Greater efficiency in overall combined business including economies of scale
- Reduction in overheads including administrative, managerial and other expenditure
- Optimal utilization of resources by elimination of unnecessary duplication
- Reduction in multiplicity of legal and regulatory compliances
- Better opportunities for employees of Transferor Company
- Enhancement of overall shareholder value
Impact on Shareholders:
- No change in ownership structure as no new shares issued
- Employees of Transferor Company will become employees of Transferee Company without break in service
- All assets and liabilities of Transferor Company will transfer to Transferee Company
- Transferor Company will stand dissolved without winding up process